Autoimmune encephalitis: suspicion in clinical practice and mimics

Diogo Costa1, Ana Sardoeira1, Paula Carneiro2

  • 1Department of Neurology, Centro Hospitalar Universitário do Porto, Porto, Portugal.

Journal of Neuroimmunology
|February 24, 2022
PubMed

Insights

Many patients tested for anti-NMDAR antibodies have conditions mimicking autoimmune encephalitis. Current diagnostic criteria may need expansion to avoid missing actual autoimmune encephalitis cases.

Area of Science:

  • Neurology
  • Immunology
  • Clinical Diagnostics

Background:

  • Autoimmune encephalitis diagnosis relies on established criteria.
  • Mimicking conditions can complicate accurate diagnosis.
  • Anti-N-methyl-D-aspartate receptor (anti-NMDAR) encephalitis is a significant autoimmune neurological disorder.

Purpose of the Study:

  • To retrospectively analyze reasons for anti-NMDAR antibody testing in neurology patients.
  • To determine the final diagnoses of patients tested for anti-NMDAR antibodies.
  • To evaluate the sensitivity and specificity of current diagnostic criteria for autoimmune encephalitis.

Main Methods:

  • Retrospective chart review of patients admitted to a Neurology ward.
  • Analysis of indications for anti-NMDAR antibody testing.
  • Review of final diagnoses, including autoimmune encephalitis and mimics.
  • Assessment of diagnostic criteria performance.

Main Results:

  • The threshold for testing anti-NMDAR antibodies was often below established diagnostic criteria.
  • A high proportion of patients tested were ultimately diagnosed with conditions mimicking autoimmune encephalitis.
  • Sensitivity and specificity analyses indicated potential limitations of current criteria.

Conclusions:

  • Alternative diagnoses are crucial to consider when autoimmune encephalitis is suspected.
  • Current diagnostic criteria for autoimmune encephalitis may require refinement or expansion.
  • Improved diagnostic strategies are needed to ensure accurate identification and management of autoimmune encephalitis.